title: To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?
authors.forename: Suleyman
authors.initials: S
authors.lastname: Aydin
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Sahin
authors.forename: Ulvi
authors.initials: U
authors.lastname: Demirel
authors.forename: Aziz
authors.initials: A
authors.lastname: Aksoy
mesh_terms: D000073861:Apelin; D005234:Fatty Liver / Q000097:blood / Q000188:drug therapy; D054439:Ghrelin / Q000097:blood*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D065626:Non-alcoholic Fatty Liver Disease; D011480:Protease Inhibitors / Q000494:pharmacology*; D015843:Serpins / Q000097:blood*
chemical_list: C115436:APLN protein, human; D000073861:Apelin; D054439:Ghrelin; D036341:Intercellular Signaling Peptides and Proteins; D011480:Protease Inhibitors; C507339:SERPINA12 protein, human; D015843:Serpins; C505799:obestatin, human